Fierce Pharma

JULY 2, 2025

Chinese regulators have approved four new drugs developed by local biopharma companies, including a first-of-its-kind molecule in blood cancer.

Biopharma 252

Biopharma 252

World of DTC Marketing

JULY 2, 2025

Healthcare is not a privilege; it is a fundamental human right. Yet today, we stand at the precipice of a crisis—nearly 12 million people in America are about to lose healthcare coverage due to expiring benefits and shifts in eligibility requirements. While patients stare down uncertainty and fear, there is a notable and unsettling absence from the conversation: Big Pharma’s voice is disturbingly silent.

Healthcare 203

Healthcare Healthcare Pharma Pharmaceutical 203

Fierce Pharma

JULY 2, 2025

After a delay, Regeneron’s BCMA-directed bispecific antibody Lynozyfic has won an FDA approval with a more convenient dosing regimen than competitor multiple myeloma offerings from Johnson & Johnson and Pfizer.

FDA 219

FDA 219

MedCity News

JULY 2, 2025

By keeping our AI and ML grounded in real-world medicine, we can shape a future where prior authorization works smarter, faster, and better for everyone involved. The post Physician-led AI: Unlocking Clinical Productivity In Prior Authorization appeared first on MedCity News.

Physicians 294

Physicians Medicine 294

Advertiser: ZoomInfo

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

Sales

Fierce Pharma

JULY 2, 2025

In this tracker, Fierce Pharma is recording the regulatory progress of in-market products, including expansions into key geographies and new indications. Some of these updates may not meet the bar for standalone stories, but we think they are still worth mentioning.

Pharma 152

Pharma Marketing 152

MedCity News

JULY 2, 2025

Bispecific antibodies are already available for treating multiple myeloma. FDA approval of Regeneron Pharmaceuticals’ new drug, Lynozyfic, comes with dosing flexibility that sets it apart from others in its class. The post FDA Approves Regeneron Multiple Myeloma Drug With Dosing Edge Over J&J and Pfizer Meds appeared first on MedCity News.

FDA 179

FDA Pharmaceutical Biopharma Pharma 179

MedCity News

JULY 2, 2025

Organon said OG-6219 did not beat a placebo in a mid-stage clinical trial whose main goal was to measure the change in pelvic pain caused by endometriosis. The twice-daily pill came from Organon’s 2021 acquisition of Forendo Pharma. The post Organon Stops Work on Endometriosis Drug After Failure in Phase 2 Test appeared first on MedCity News.

Pharma 165

Pharma Biopharma 165

pharmaphorum

JULY 2, 2025

Finland's GlucoModicum thinks it is in the lead in the race to bring a non-invasive continuous glucose monitor (CGM) to market.

Leads 63

Leads Marketing 63

MedCity News

JULY 2, 2025

Nordic Capital acquired a majority stake in health data platform Arcadia. Together, the two aim to accelerate the company’s mission of advancing value-based care through AI and data analytics. Arcadia CEO Michael Meucci views the deal as both a validation of the company’s strategy and part of a broader wave of healthcare investments focused on interoperability, AI and payment reform.

Healthcare 147

Healthcare Healthcare 147

pharmaphorum

JULY 2, 2025

Shionogi has added to its antibiotics pipeline by taking an option on a preclinical-stage candidate from BioVersys for non-tuberculous mycobacteria.

65

65

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

Sales

MedCity News

JULY 2, 2025

To remain resilient amid the volatility, skilled nursing facilities s need to stay on top of what’s impacting operations and consider strategic opportunities. Here are important trends to watch. The post Industry Pressures and Possibilities: What’s Ahead for Skilled Nursing Facilities appeared first on MedCity News.

Patients 165

Patients Healthcare Healthcare 165

pharmaphorum

JULY 2, 2025

The UK has revealed a new 'innovator passport' designed to accelerate the rollout of proven medtech in the NHS.

61

61

MedCity News

JULY 2, 2025

Co-occurring ADHD and eating disorders can intensify the symptoms of each other. Impulsivity can lead to binge eating or purging and emotional dysregulation can make it challenging to cope with life’s difficulties. Addressing both ADHD and an eating disorder at the same time can best forge the path to recovery and healthy coping. The post Navigating Co-Occurring ADHD and Eating Disorders appeared first on MedCity News.

Leads 165

Leads Education Patients Medical 165

Pharmacy Times

JULY 2, 2025

The treatment becomes the first approved BCMAxCD3 bispecific antibody with the potential to achieve biweekly or monthly dosing in patients with relapsed/refractory multiple myeloma.

FDA 62

FDA Patients 62

Advertiser: ZoomInfo

ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!

Marketing

PharmaTech

JULY 2, 2025

The company is voluntarily recalling one lot of cefazolin for injection, USP, 1 gram per vial due to customer complaints of the wrong product being included in a carton.

64

64

European Pharmaceutical Review

JULY 2, 2025

Sandoz has begun construction of a new biosimilars production facility in Brnik, Slovenia. The $440 million centre will manufacture injectable sterile products, bringing the company’s total planned and ongoing investment in the country to over $1.1 billion before the end of the decade, by 2029. The new high-tech facility will produce both existing and upcoming biosimilar medicines in Sandoz’s portfolio.

Manufacturing 52

Manufacturing Networking Medicine Pharma 52

Pharma Marketing Network

JULY 2, 2025

In the digital-first era, social media marketing strategies are reshaping how pharmaceutical companies engage with healthcare professionals, patients, and caregivers. These strategies are no longer optional; they are essential. From awareness campaigns to real-time engagement, pharma brands that embrace digital transformation are seeing meaningful results across platforms.

Media 52

Media Marketing Pharma Education 52

PharmaTech

JULY 2, 2025

The expansion of the Kentucky site accounts for $80 million of the announced investment, with the remaining money earmarked for facilities in Michigan.

Pharma 59

Pharma 59

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

Sales

Eversana Intouch

JULY 2, 2025

EVERSANA INTOUCH’s Dan Gandor, executive vice president and head of omnichannel and digital transformation, was a featured thought leader at the recent Digital Health Coalition Group (DHC) Social-First and Brand Insights Roundtable, held June 18 in Deerfield, Illinois at Amgen. This exclusive event convened senior pharma marketers to explore how social-first strategies are reshaping brand planning and engagement models.

Marketing 64

Marketing Pharma Healthcare Healthcare 64

Pharmaceutical Commerce

JULY 2, 2025

As drug development increasingly targets multiple indications, pharma companies must make strategic branding decisions—balancing regulatory requirements, market dynamics, and patient safety—to choose between single-brand or multi-brand approaches.

Pharmaceutical 59

Pharmaceutical Safety Pharma Marketing 59

pharmaphorum

JULY 2, 2025

AstraZeneca chief executive Pascal Soriot is reportedly considering moving the company's stock exchange listing from the UK to the US

58

58

Pharmaceutical Commerce

JULY 2, 2025

In the final part of his Pharma Commerce video interview, Mark Sawicki, PhD, Cryoport Systems’ president and CEO, predicts how he anticipates the model growing over the next three to five years, especially as global demand and regulatory complexities increase.

Distribution 52

Distribution Pharma 52

Advertiser: ZoomInfo

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

Sales

Pharmacy Times

JULY 2, 2025

Research reveals a link between estrogen plus progestin hormone therapy and increased breast cancer risk in young women, urging personalized treatment approaches.

42

42

Pharmaceutical Technology

JULY 2, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Marketing 52

Marketing Transportation Biopharma Patients 52

Pharmacy Times

JULY 2, 2025

Lung transplant recipients were found to be at heightened risk of developing secondary lung infections, including bacterial and fungal infections, due to unique risk factors.

52

52

Pharmaceutical Technology

JULY 2, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Food and Drug Administration 52

Food and Drug Administration Media Pharmaceutical Government 52

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Pharmacy Times

JULY 2, 2025

Manish Agrawal, MD, discusses the implementation of psilocybin-assisted therapy in a community cancer setting, highlighting its potential to provide sustained relief from depression and anxiety and its significant efficacy advantage over selective serotonin reuptake inhibitors for patients with cancer.

Patients 29

Patients 29

Pharmaceutical Technology

JULY 2, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Food and Drug Administration 52

Food and Drug Administration Media Marketing Pharmaceutical 52

Pharmacy Times

JULY 2, 2025

Pharmacy leaders from Cone Health discuss how robotic compounding technologies have improved safety, accuracy, and reliability in hazardous and sterile medication preparation across oncology and acute care settings.

Safety 26

Safety Medical 26

Pharmaceutical Technology

JULY 2, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Pharmaceutical 52

Pharmaceutical Media Government Marketing 52

Advertiser: ZoomInfo

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

Sales Strategy